Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing
Biospace News
-
July 15, 2019
Launch
H2-Pharma and CHEPLAPHARM Announce Launch of ETOPOPHOS Injection
Launch
Clover Health Launches Clover Therapeutics, a New Research Subsidiary to Develop Treatment for Chronic Diseases
Launch
Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform – July 1, 2019
Launch
Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell Platform
Launch
Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch
Biospace News
-
June 28, 2019
0
Launch
Nervgen Pharma Launches Multiple Sclerosis Program Targeting Nerve Remyelination
Biospace News
-
June 26, 2019
0
Launch
Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User...
Firstwordpharma News
-
June 25, 2019
0
Launch
NIH launches large TB prevention trial for people exposed to multidrug-resistant...
Firstwordpharma News
-
June 25, 2019
0
Launch
ANI Pharmaceuticals Announces Launch of Ranitidine Capsules
Biospace News
-
June 25, 2019
0
1
2
3
...
9
Page 1 of 9
- Advertisement -
MOST POPULAR
China moves to expand cancer medicine access ...
March 8, 2019
HAMLET Pharma Appoints Issa PR to Launch First Major Clinical Trials...
May 20, 2019
Concert Pharmaceuticals to Present CTP-543 Phase 2 Interim Data in Alopecia...
April 11, 2019
2019 BioSpace Life Sciences Ideal Employer Survey
June 7, 2019
Load more
HOT NEWS
Commercial
Algiax Pharmaceuticals Announces New Executive Team and Clinical Trial Plan for...
Newer Targets
Moleculin Announces Conference Call to Discuss Significant Discovery For Lung Cancer...
Commercial
Ampio Appoints Moss Adams LLP as the Company’s New Independent Auditor
Clinical
Progress Update on GDC-0084 Program
